560MO Maintenance with 5FU/LV-Aflibercept after induction with FOLFIRI-Aflibercept vs FOLFIRI-Aflibercept until progression in older patients (pts) in 2nd line metastatic colorectal cancer (mCRC): The randomized AFEMA trial

P. García Alfonso,M.E. Elez Fernandez,J. Soto Alsar, D. Paez,A. Fernandez Montes,B. Grana Suarez, A. Salud, A. Yubero Esteban, M.A. Gomez España,I. Macias Declara, G.A. Quintero Aldana,C. Lopez Lopez, T. Fernandez Rodriguez,M.C. Gravalos Castro, E. González-Flores, M. Guix Arnau,B. García Paredes,J.J. Reina Zoilo,J. Sastre Varela, E. Aranda Aguilar

Annals of Oncology(2023)

引用 0|浏览4
暂无评分
关键词
colorectal cancer,afema trial,lv-aflibercept,folfiri-aflibercept
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要